Advertisement · 728 × 90
#
Hashtag
#YsiosPortfolio
Advertisement · 728 × 90
Post image

#PortfolioNews | Memo Therapeutics partners with CSL to advance recombinant polyclonal IgG, validating its DROPZYLLA® platform. 🚀🧬

👉 buff.ly/uCOUhUh

#YsiosPortfolio

0 0 0 0
VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment

VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment

📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊

🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need

👉 buff.ly/aO4iHwV

#YsiosPortfolio #vc

3 0 0 0
Video

#PortfolioNews I Our #portfolio company ONA Therapeutics strengthens leadership to accelerate first-in-class #ADCs targeting resistant #cancer cells & advancing toward #clinical development.

📢 Read more here https://buff.ly/4gK9vh3

#Oncology #Biotech #Pharma #YsiosPortfolio

2 0 0 0